Leveraging the molecular heterogeneity of patient -derived tumor samples to simulate clinical trial settings and model combination treatments

Category Primary study
JournalCANCER RESEARCH
Year 2012
This article has no abstract
Epistemonikos ID: 99e7f5107cd6085f0b27d1ff3aa4e00069ebf09d
First added on: Feb 05, 2025